Navigation Links
Professor Wing Wong Elected to the National Academy of Sciences
Date:5/18/2009

aTyr Pharma Scientific Advisory Board Member Recognized for Development of Statistical Methods and Software

SAN DIEGO, May 18 /PRNewswire/ -- Wing Hung Wong, Professor of Statistics and of Health Research & Policy at Stanford University has been elected to the US National Academy of Sciences. Election to the National Academy of Sciences is one of the highest honors that can be accorded to a scientist in the US and this honor recognizes Professor Wong's significant contributions in developing statistical methods and software for analyzing complex databases, such as those from high throughput genomics research.

With over 100 publications in peer reviewed journals, Professor Wong has developed ground-breaking methods for turning large data sets into useful information about biological systems. His contributions to biological advancements through computational analysis are many, and include methods and algorithms for the analysis of gene expression data from microarray chips, identification of gene regulatory elements in developmental genomics, and elucidation of genetic networks.

According to Professor Paul Schimmel, co-founder of aTyr Pharma and fellow NAS member: "We are pleased to see this well deserved recognition of Professor Wong's valuable contributions to computational analysis of complex biological data. As a member of our scientific advisory board, Professor Wong has provided invaluable guidance for building aTyr's platform of naturally occurring, therapeutic splice variants of human tRNA synthetases. His work with genomics data has accelerated understanding of biology and paved the way for significant health advances." aTyr Pharma congratulates Professor Wong on this well deserved honor.

    Company Contact:                          Media Contact:
    Cheryl Quinn                              Jennifer James
    Director of Business Development          Alta Partners
    aTyr Pharma                               (415) 362-4022
    858-731-8390                              jjames@altapartners.com
    cquinn@atyrpharma.com


'/>"/>
SOURCE aTyr Pharma
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Professor Hanna Nohynek Joins Encorium as Head Consultant of its Clinical Vaccine Research Team
2. University of Minnesota Professor Dr. David Pui to Speak at American Filtration and Separation Society Conference
3. Professors Raphael Haftka and C. T. Sun to receive AIAA-ASC James H. Starnes Jr. Award
4. Professors Raphael Haftka and C. T. Sun to receive AIAA-ASC James H. Starnes, Jr. Award
5. Professor K. C. Nicolaou Speaks at WuXi AppTec
6. Nyenrode Honorary Doctorate for Professor Michael E. Porter
7. Thin films research lands engineering professor Air Force Young Investigator Award
8. Gift Aids Professor's Research into Vein Treatment
9. Kiadis Pharma Announces Continued Collaboration With Professor Velardi on its Lead Product ATIR(TM)
10. UCF professor develops vaccine to protect against black plague bioterror attack
11. Yale professor T.P. Ma awarded the Connecticut Medal of Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 2016  Global demand for enzymes is forecast ... to $7.2 billion.  This market includes enzymes used ... biofuel production, animal feed, and other markets) and ... Food and beverages will remain the largest market ... of products containing enzymes in developing regions.  These ...
(Date:6/27/2016)... ... June 27, 2016 , ... Newly created ... and solutions to the healthcare market. The company's primary focus is on new ... and marketing strategies that are necessary to help companies efficiently bring their products ...
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
(Date:6/23/2016)...   Boston Biomedical , an industry leader ... target cancer stemness pathways, announced that its lead ... Designation from the U.S. Food and Drug Administration ... gastroesophageal junction (GEJ) cancer. Napabucasin is an orally ... stemness pathways by targeting STAT3, and is currently ...
Breaking Biology Technology:
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:4/13/2016)... -- IMPOWER physicians supporting Medicaid patients in Central ... in telehealth thanks to a new partnership with higi. ... patients can routinely track key health measurements, such as ... when they opt in, share them with IMPOWER clinicians ... retail location at no cost. By leveraging this data, ...
(Date:3/31/2016)... PROVIDENCE, R.I. , March 31, 2016  Genomics ... leadership of founding CEO, Barrett Bready , M.D., ... addition, members of the original technical leadership team, including ... Vice President of Product Development, Steve Nurnberg and Vice ... have returned to the company. Dr. Bready ...
Breaking Biology News(10 mins):